Matthew Stanton
Stock Analyst at Jefferies
(0.56)
# 4,156
Out of 5,124 analysts
7
Total ratings
50%
Success rate
-25.07%
Average return
Main Sectors:
Stocks Rated by Matthew Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AZTA Azenta | Upgrades: Buy | $30 → $38 | $33.26 | +14.25% | 2 | Oct 30, 2025 | |
| RGEN Repligen | Maintains: Hold | $145 → $135 | $163.86 | -17.61% | 1 | Sep 12, 2025 | |
| CYRX Cryoport | Downgrades: Hold | $20 → $8 | $9.60 | -16.67% | 2 | Aug 7, 2024 | |
| LAB Standard BioTools | Initiates: Buy | $3.25 | $1.28 | +153.91% | 1 | Apr 4, 2024 | |
| BLFS BioLife Solutions | Initiates: Buy | $22 | $24.18 | -9.02% | 1 | Apr 4, 2024 |
Azenta
Oct 30, 2025
Upgrades: Buy
Price Target: $30 → $38
Current: $33.26
Upside: +14.25%
Repligen
Sep 12, 2025
Maintains: Hold
Price Target: $145 → $135
Current: $163.86
Upside: -17.61%
Cryoport
Aug 7, 2024
Downgrades: Hold
Price Target: $20 → $8
Current: $9.60
Upside: -16.67%
Standard BioTools
Apr 4, 2024
Initiates: Buy
Price Target: $3.25
Current: $1.28
Upside: +153.91%
BioLife Solutions
Apr 4, 2024
Initiates: Buy
Price Target: $22
Current: $24.18
Upside: -9.02%